Connect with us

CBD

Tilray Shares Climb Higher on Roll Out of New Medical Cannabis Brand Symbios

Published

on

June 10, 2021 (Investorideas.com Newswire) Tilray Inc. shares traded 11% higher after the company announced the launch of a new medical cannabis brand, Symbios, that would offer medical users a wider range of formats and cannabinoid potencies to offer points at an improved price.

Tilray Inc. (TLRY: NASDAQ; TLRY: TSX), global provider of consumer-centric packaging, lifestyle and medical uses, yesterday announced the launch of a new medical cannabis brand called “Symbios,” which the company expects to complement its medical brand becomes portfolio in Canada.

Tilray announced that the new brand line was created to offer a much wider range of product delivery option formats that offer unique cannabinoid ratios at lower prices. The company stated that the Symbios branded product line will enable medical patients to choose from a wide range of products including flowers, oils and pre-rolls to meet their health and wellness needs.

Company CEO Irwin D. Simon commented, “Medical cannabis innovation and patient care are at the core of Tilray’s new business and global growth strategy. Looking ahead, we continue to focus on building the momentum of our three medical brands – Symbios, Aphria and Tilray – while meeting the great and growing demand for new, high quality cannabis products that promote health, wellbeing and wellbeing. “

Tilray also announced yesterday the launch of “new highly potent medical cannabis topicals under the Aphria brand that are designed to combat inflammatory joint disease by regulating tissue inflammation when applied topically to the skin”. The company stated that “the new topicals are made from a vegan and cruelty-free cream formulation and contain CBD 750 (with 750 mg of CBD) and Balance 750 (with 375 mg of THC and 375 mg of CBD).”

Jim Meiers, President of Tilray Canada, commented, “Symbios and our new Aphria topical treatments are exciting new additions to our medical portfolio in Canada, offering our patients a wider choice of unique product formats to suit their needs and preferences Launching cannabinoid medicine options that meet patient needs. We are committed to building our leading position in Canada now and in the future. “

The company announced that the new Symbios branded products and high-potency topical product offerings from Aphria will be added to its portfolio of many other products currently available to medical patients through Aphria’s online patient portal. The network currently sells cannabis oils, mouth sprays, soft gels, vapes, and whole dried flowers.

The report found that Aphria was one of the first companies to provide access to legal medical cannabis and is now one of the leading Canadian and global medical cannabis providers.

Operating in Canada, Europe, Australia, Latin America and the United States, Tilray described its business as “a leading global cannabis lifestyle and consumer products company”. The company’s products include a wide range of cannabis offerings and infused products, alcoholic beverages, and hemp-based foods. The company’s research, cultivation, production and packaging activities support more than 20 brands in more than 20 countries.

Tilray started the day with a market cap of around $ 9.0 billion with approximately 447.4 million shares outstanding. TLRY shares opened today 2% higher at $ 20.67 (+ $ 0.45, + 2.23%) from yesterday’s closing price of $ 20.22. The stock was trading between $ 20.43 and $ 23.04 per share today and is currently trading at $ 22.56 (+ $ 2.23, + 11.03%).

Disclosure:

1) Stephen Hytha compiled this article for Streetwise Reports LLC and provides Streetwise Reports services as an independent contractor. He or members of his household own securities from the following companies mentioned in the article: None. He or members of his household are paid by the following companies mentioned in this article: None.

2) The following companies mentioned in this article are poster sponsors of Streetwise Reports: None. Click here for important information on sponsorship fees.

3) The comments and opinions expressed are those of the respective experts and not those of Streetwise Reports or its officers. The above information is provided for informational purposes only and does not constitute a recommendation to buy or sell any securities.

4) The article does not constitute investment advice. Each reader is encouraged to consult their personal financial expert, and any action that a reader takes based on the information presented here is their own responsibility. By opening this page, every reader accepts the Streetwise Reports Terms of Use and the full legal disclaimer. This article is not an invitation to invest. Streetwise Reports does not provide general or specific investment advice and the information in Streetwise Reports should not be viewed as a recommendation to buy or sell any securities. Streetwise Reports does not endorse or recommend the business, products, services, or securities of any company mentioned in Streetwise Reports.

5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, and persons interviewed for articles and interviews on the website, may have a long or short position in the referenced securities. Directors, officers, employees or immediate family members are prohibited from buying and / or selling such securities in the open market or otherwise from the time an article is decided to be published until three business days after the article is published. The above prohibition does not apply to articles that essentially only reproduce previously published company communications.

6) This article does not constitute medical advice. Officers, employees and contributors to Streetwise Reports are not registered health professionals. Readers should always contact their health care professional for medical advice.

Disclaimer / Disclosure: Investorideas.com is a digital third-party news, article and stock research publisher, creating original content including videos, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our website does not make recommendations for buying or selling stocks, services, or products. Nothing on our websites should be construed as an offer or solicitation to buy or sell any product or security. All investments involve risks and possible losses. This website is currently rewarded for news posting and distribution, social media and marketing, content creation, and more. Disclosure takes place for every remunerated press release, published / created content, if necessary, but otherwise the news was not remunerated and published in the sole interest of our readers and followers. Contact management and IR of each company directly with specific questions.

For more disclaimer information: https://www.investorideas.com/About/Disclaimer.asp Learn more about your press release and our other news services on Investorideas.com’s Newswire https://www.investorideas.com/News- Upload / and Tickertagstocknews.com

Global investors must adhere to each country’s regulations. Please read Investorideas.com’s privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Follow us on StockTwits

Buy a cannabis guest post on Investorideas.com

CBD

Facebook must weed out these bogus CBD cannabis extract miracle cures

Published

on

The Penman Law of Health Scams states that the more ailments a cure claims to be able to cure, the less likely it is to cure any of them.

So I have no doubt that Facebook plugs for a “miracle” cannabis extract are 100% scams.

These start with the names of celebrities being used without their consent – the last time I saw posts with pictures by Esther Rantzen.

Clicking on her picture leads to an alleged article in the American magazine People promoting cannabidiol, or CBD, which is sold in sweet form as Kara’s Orchards CBD Gummies.

The article claims that Esther started a company to sell the stuff and says, “It can help thousands of people live pain-free lives and much happier lives.”

It goes on to say that big drug companies are threatening to sue them because their gums are 90% cheaper.

And it quotes a number of their supposed celebrity customers, including Hugh Laurie gushing: “Esther Rantzen gave me a sample of Kara’s Orchards CBD gummies and the product is a miracle worker.”

Fake: Hugh Laurie in a fabricated article

Fake: Judi Dench quote is made up

Judi Dench raves: “The progress that Esther Rantzen has made in the CBD industry is remarkable. I wouldn’t believe it if I hadn’t had the chance to try it out for myself. “

All of this is pure fiction.

This fake People magazine article is as fictional as similar Facebook posts that use David Attenborough’s name and refer to an alleged Time magazine article about his CBD rubber line claiming his lucky customers are Holly Willoughby and Jeremy Clarkson.

JK Rowling’s name has also been taken advantage of by CBD charlatans on Facebook.

Clicking the link in Esther Rantzen’s article leads to a website that makes amazing claims about CBD, saying that it can reverse diseases like cancer, arthritis, Alzheimer’s, strokes, diabetes, schizophrenia “and much more”.

Kara’s Orchards CBD gummies

Online review sites are inundated with complaints from people saying they have been overcharged and are struggling to get a refund.

“My husband has arthritis in one shoulder. I thought I would get a bottle as they were on sale at £ 39.60 a bottle and one for free, ”75-year-old Heather Nunn told me.

“The offer was limited in time, it was 3 hours away so I didn’t waste time placing my order.

“Imagine my horror when they took £ 198 off my account for five bottles.”

Heather complained but was told it was too late to cancel the order, she would have to wait for it to arrive and then return the extra bottles.

“I’m so mad that I fell for this terrible marketing ploy,” she said.

“I know a lot of fellow victims, many in my age group, who were betrayed by it. Facebook has been made aware of this but will not do anything because the company does not appear to have violated ‘community standards’.”

The Kara’s Orchards website does not contain any contact information. Order fulfillment is through a company called Prime Health Zone who provide a return address in Basildon, Essex and have not answered my questions.

Esther Rantzen told me she was “absolutely shocked” by the fraud.

She said, “This is really gross because God knows we all fear an outbreak of chronic disease and using this stuff to give people hope is disgusting. I’m not into Facebook, gummy bears, cannabis, or ripping off vulnerable people with chronic pain. May the deceivers cook in their own oil. “

Esther isn’t the only one angry. Family Doctor John Cormack was disgusted when he saw the medical claims for CBD gums and described them as “99.99% marketing and 0.01% fact”.

Dr. John Cormack of Greenwood Surgery near Chelmsford, Essex. Image by John Ferguson.

“If these products really do what they say they should, shouldn’t the medical professionals have gotten it?” Said the doctor from Chelmsford, Essex.

“Wouldn’t overworked NHS Docs struggling to fit a quart in a pint pot say to their patients,” You don’t have to tell me what’s wrong with you or have me examine you. We have finally found a panacea, backed by scientific data. Just take these pills and you will miraculously recover. “

He cited research showing that wherever the effects of CBD on certain diseases were examined, only “weak or very weak” evidence of benefit was found.

The exceptions were for some types of seizures and potentially anxiety-related and substance-dependent disorders.

“To get any benefit, you need to know the recommended dose in these specific cases and find a product that meets your dosage needs – not easy when you are in the area of ​​poorly regulated or unregulated products,” he said.

“Another concern is that patients may be so convinced of the benefits of CBD and the content of these advertisements will undermine their confidence in their prescribed medication to such an extent that they could replace the quack drug with the real thing – with very serious consequences.”

And I would add this, if CBD really does a fraction of the things it claims to do, then why do Shysters have to create fictional posts that use fake celebrity endorsements to sell it?

When I first made Facebook aware of the fraudulent post via its automatic reporting system, I received a message that it would not be removed.

“The contribution you reported has been checked and does not violate our community standards,” is the shocking verdict of the platform.

It wasn’t removed until I went to the Facebook press office and explained what was going on.

“We are devoting significant resources to addressing these types of activities,” said a spokesman.

“It is important to us that content on Facebook is not used to encourage fraudulent behavior, such as using images of public figures to mislead people. Our systems get better when people report such behavior. “

Continue Reading

CBD

Revealing Covid-19 impact on CBD Isolate market growth over 2021-2026

Published

on

Uncovering the Impact of Covid-19 on CBD Isolate Market Growth in 2021-2026

Category: #business |
From administrator |
Published: 23 minutes ago

| Product ID: 3878547 |

The main objective of the latest research report on the CBD Isolate Market Size is to predict the performance of the industry for years to come, taking into account competitive dynamics and the regional landscape. In addition, the study highlights key growth drivers and profitable prospects that will increase the compensation latitude of the market in the forecast period 2020-2025. It also identifies barriers to industry growth as well as strategies to mitigate their impact.

Additionally, the Business Intelligence report provides an in-depth assessment of the market segmentation to help investors discover the main areas with high sales potential. It also provides up-to-date information on the Covid-19 pandemic to help stakeholders make effective decision-making for the future.

Main highlights from the COVID-19 impact analysis:

  • Effects of Covid-19 on society and the economy
  • Effects of the pandemic on market development
  • Interventions in the supply and demand chain

Request a sample copy of this report @ https://www.business-newsupdate.com/request-sample/161691

Overview of the regional landscape:

  • The major regional contributions to the CBD Isolates market are North America, Europe, Asia-Pacific, the Middle East, and Africa and South America.
  • The contribution of each region to the growth of the overall market is thoroughly analyzed in the report.
  • Key features such as pricing patterns, returns, total sales, and growth rate forecasts for each region are included in the report.

More Highlights from the CBD Isolate Market Report:

  • The product range of the CBD Isolate market is in marijuana-derived and hemp-derived.
  • Sales and growth rate estimates are provided for each product type.
  • Details of the market share, growth rate, and production patterns of each product type are described in the report.
  • The scope of the CBD Isolates market is categorized into Cosmetics Industry, Food Industry, Pharmaceutical Industry, Other, Geographic, the detailed analysis of the production and trade of the following countries is covered in Chapter 4.2, 5:, USA, Europe, China, Japan and India.
  • The report provides details of each application’s market share along with its growth rate over the forecast period.
  • Major players in the CBD isolate market are Emblem Cannabis Oils, Cannavest, PharmaHemp, Aphria, Select, CBD American Shaman, Endoca, NuLeaf Naturals, Kazmira, The Lab, Whistler, Absolute Terps, Green Road, HempLife Today, Medical Marihuana, Folium Biosciences , Freedom Leaf, CW Hemp / CW Botanicals, and Canopy Growth Corporation
  • The report cites key information about the products and services produced, as well as the market valuation and production framework of the main players.
  • A thorough analysis of the supply chain, from dealers, distributors, to customers, is provided in an easy-to-understand manner.
  • A comprehensive study of the profitability of a new project is conducted using Porter’s Five Forces Analysis and SWOT assessment tools.

Key questions answered in the report:

What will be the growth rate of the CBD Isolate market?

What are the key factors driving the global CBD isolate market?

Who are the major manufacturers in the CBD isolate market?

What are the Market Opportunities, Market Risk, and Market Overview of the CBD Isolate Market?

What is Sales, Revenue, and Price Analysis from Top Manufacturers in the CBD Isolate Market?

What CBD Isolate Market Opportunities and Threats Are Vendors Facing in the Global CBD Isolate Industry?

What is Sales, Revenue, and Price Analysis by Types and Uses of the CBD Isolate Market?

Request customization for this report @ https://www.business-newsupdate.com/request-for-customization/161691

Continue Reading

CBD

What is the strongest CBD oil I can get?

Published

on

We include products that we believe will be useful to our readers. If you buy from links on this page, we may earn a small commission. Here is our process.

CBD, or cannabidiol, is a chemical compound and one of several cannabinoids found in the cannabis sativa plant. There are many forms of CBD, including oils. Some of the strongest products can contain up to 7,500 mg of CBD per 30 ml.

CBD has become a popular ingredient in oils, edibles, topicals, and even cosmetics. CBD does not cause the “high” typically associated with cannabis use. The cause of the “high” is another cannabinoid called tetrahydrocannabinol (THC).

People interested in CBD products and regular consumers alike may marvel at the strongest CBD oil on the market.

In this article, we provide a list of highly potent CBD oils and other CBD products. We also discuss the potential benefits and risks of using strong CBD.

Confused About CBD? Read our complete buying guide here.

Is CBD Legal?? Hemp-derived CBD products with less than 0.3% THC are legal at the federal level, but are still illegal under some state laws. On the other hand, cannabis-derived CBD products are illegal nationwide, but legal under some state laws. Check local laws, especially when traveling. Also, keep in mind that the Food and Drug Administration (FDA) has not approved any over-the-counter CBD products that may be inaccurately labeled.

Below are some examples of high potency CBD oils and tinctures. Oils and tinctures go through slightly different extraction processes. Manufacturers produce CBD oils using carbon dioxide to extract the CBD, while tinctures undergo a process using alcohol.

Learn more about CBD tinctures here.

Please note that the author of this article has not tried these products and all information presented is research-based. All of the CBD products featured in this article have passed our rigorous review process.

Zaural full spectrum CBD oil drops

Zatural Full Spectrum CBD Oil Drops contain hemp seed oil and essential oils from peppermint, spearmint, coffee, cinnamon and lemon-lime.

The company states that the product is THC-free.

This product is available in 1, 2, and 4 fluid ounces (fl oz) bottles that contain 300–6,000 milligrams (mg) of CBD.

Zaural Full Spectrum CBD Oil Drops can be bought online.

Spruce 2,400 mg laboratory-grade CBD oil

Spruce’s 2,400 mg full-spectrum CBD oil provides 80 mg of full-spectrum CBD per 1 milliliter (ml) dose, which is equivalent to a full pipette.

The oil is organic and does not contain any additional flavors. The carrier oil is hemp seed oil, and the product is vegan and gluten-free.

This product contains 0.3% THC and the company states that a person ingesting it could test positive for cannabis.

Use the code “MNT” for 15% discount and free shipping.

Spruce 2,400 mg laboratory-grade CBD oil is available for purchase online.

NuLeaf Naturals full spectrum hemp CBD oil

NuLeaf Naturals offers a 6,000 mg full spectrum CBD oil. The company extracts the CBD from organic hemp grown in Colorado.

NuLeaf Naturals uses full spectrum CBD and organic hemp seed oil to make their CBD oil products. The product is organic and tasteless.

People can also choose to buy a single bottle or buy packs of 3 or 6 bottles.

NuLeaf Naturals full spectrum hemp CBD oil can be purchased online.

MyNaturalCBD full spectrum CBD oil tincture

This full spectrum CBD oil from MyNatural CBD contains around 167 mg of CBD per ml and around 8.2 mg of CBD per drop.

MyNatural CBD offers CBD oils in strengths of 300, 1,000 and 2,500 mg.

The company states that the product has less than 0.3% THC. contains

MyNaturalCBD full spectrum CBD oil tincture can be bought online.

CBDMD CBD Oil Tincture Drops

CBDMD’s Premium CBD Oil contains 7,500 mg of broad spectrum CBD per 1 fl oz bottle.

It also contains additional cannabinoids, including cannabinol (CBN) and cannabigerol (CBG). This tincture is available in natural, mint, orange or berry flavors.

It’s vegan and gluten free.

The company guarantees this product contains undetectable levels of THC.

Use the code HEALTHLINE for a 20% discount on all orders.

CBDMD CBD tincture drops can be bought online.

Veritas Farms full spectrum CBD tincture

Veritas Farms produces a full spectrum CBD tincture with up to 2,000 mg of CBD per bottle. Like many others, this product is also available in lower strengths.

Veritas Farms also offers its product in five different flavors, including watermelon and strawberry. The flavored versions contain organic stevia and other natural oils. The tasteless version is free from these ingredients.

The company uses organic coconut oil in its products.

Veritas Farms states that the product contains 0.3% THC or less.

Veritas Farms’ full spectrum CBD tincture can be purchased online.

While there is an abundance of research into the effects of cannabis and THC, there are very few high quality human studies examining CBD on its own.

However, new research comes out every day, which means that our knowledge of CBD and its effects is likely to increase significantly in the decades to come.

It is difficult for experts to predict exactly how differences in strength will affect the effectiveness of CBD.

Based on the results of a 2020 review, CBD appears to be relatively safe at various dosages. However, the authors did not set a specific dose or range of doses that they believed would benefit everyone.

Most of the studies included in this review rated daily doses of 300–600 mg of CBD, but some studies reported doses up to 2,000 mg per day.

Everyone reacts differently to CBD, so it’s best for people who are first time using CBD to start on a lower dose.

Buying a product that has a higher concentration of CBD in it can be more cost effective for some people.

Someone using 300 mg of CBD for chronic pain or anxiety would use 12 full droppers of a 25 mg of CBD oil. However, you could get a similar dose of 300 mg using just a drop and a half of a 2,000 mg CBD oil.

While stronger products may deliver more CBD per unit, they can result in inaccurate dosing.

Learn more about CBD dosage here.

According to a 2018 report by the World Health Organization (WHO), even at doses above 150 mg per kilogram (kg) of body weight, CBD does not appear to cause significant side effects.

The Food and Drug Administration FDA warns that using CBD products can cause the following side effects:

  • feeling sleepy
  • Gastrointestinal problems
  • diarrhea
  • decreased appetite
  • Mood changes such as irritability
  • Liver damage (certain drug interactions)
  • Interactions with alcohol and other drugs

The FDA has only approved one CBD product called Epidiolex for severe forms of epilepsy in children. The FDA doesn’t regulate other CBD products.

Learn more about the side effects of CBD here.

In a 2017 study, researchers rated the label accuracy of 54 CBD products from 31 companies. They tested a range of products, including oils, tinctures, and steam formulas. Their third-party laboratory analysis showed that only 30.95% of the products had specified concentrations of CBD.

According to the authors, CBD oils had more accurate labeling than tinctures and steam formulas.

Most reputable CBD manufacturers, however, will provide third-party laboratory results to their customers.

Consumers should always be careful when buying CBD, especially high potency products. Highly effective CBD products can be inaccurately labeled. Some products may not even contain CBD.

Some CBD products can contain enough THC to give a positive result on a drug test.

Learn more about THC and drug testing here.

CBD is a popular ingredient in consumer products. Current preliminary research suggests that CBD may prove beneficial in treating a number of conditions, including epilepsy, anxiety, and other mood disorders, as well as some forms of chronic pain.

Learn more about the potential benefits of CBD oil here.

However, higher quality, controlled studies are needed to validate the medical uses of CBD.

People who currently use CBD products but think they could benefit from more powerful alternatives can use this article for guidance. People who have never used CBD but are interested in giving it a try should start with a lower dose and gradually work their way up to stronger products.

People should also discuss CBD with a doctor or health care provider before taking it, as it can interact with other medications a person is taking.

Learn more about cannabinoids and possible drug interactions here.

Continue Reading
Advertisement

Trending